Typical India planning band
Living donor liver transplant may commonly plan around USD 42,000-1,10,000+ depending on MELD, donor workup, ICU, and complications.
India vs UAE liver transplant planning
Liver transplant comparison must begin with legal and medical feasibility, not package prices. Families need MELD score, infection status, liver cancer criteria, donor relationship and safety, graft anatomy, authorization, licensed transplant facility acceptance, ICU depth, blood products, immunosuppression, complication reserve, nearby stay, and home hepatology follow-up. India is often lower for living donor pathways; UAE care may fit selected residents or cases accepted by licensed facilities under UAE law.
Short answer for liver transplant families
India is usually lower for a complete living donor liver transplant pathway when donor workup, recipient surgery, ICU, medicines, lodging, and early monitoring are included. The UAE may be practical only when the patient is accepted by a licensed UAE transplant facility, the donor route is legal, and insurance or resident status supports the high total cost.
Use INR, AED, and USD as planning references only. Refresh INR through FBIL and AED through the Central Bank of the UAE before deposit; transplant medicines, ICU, and extended stay may be billed in separate lines.
Share the basics and the Virello team will guide you toward the next step.
Prefer email? Write to support@virellohealth.com.
Reviewed 2026-08-25
Clinical review: Virello Health transplant review team · Editorial review: Virello Health medical travel editorial team
Educational UAE comparison only. It cannot determine transplant eligibility, donor relationship validity, licensed-facility acceptance, authorization timing, graft availability, survival, or flight safety. Any commercial organ arrangement is illegal and unsafe.
Living donor liver transplant may commonly plan around USD 42,000-1,10,000+ depending on MELD, donor workup, ICU, and complications.
UAE liver transplant planning can exceed USD 1,20,000-3,50,000+ in high-acuity private or insured settings.
Verify donor relationship, free consent, licensed facility acceptance, and UAE or India transplant rules before travel.
Recipient severity, donor anatomy, ICU days, blood products, infection, graft dysfunction, and immunosuppression drive cost.
Side-by-side view
Use this table to check whether two quotes are describing the same patient pathway before comparing the final number.
| Factor | India | UAE | Patient note |
|---|---|---|---|
| Best cost fit | Often stronger for living donor transplant with lower donor-recipient and long-stay cost. | Can fit selected UAE residents if licensed facility acceptance and coverage are clear. | Legal route first. |
| Donor route | Living donor documentation and authorization are central. | UAE law bans organ sale and requires regulated donation routes. | No brokered donor. |
| ICU depth | High-volume transplant ICU can be compared across major cities. | UAE licensed centers may offer strong ICU but at higher cost. | Ask included ICU days. |
| Cancer criteria | HCC transplant review needs imaging and tumor-board criteria. | UAE center must confirm eligibility and allocation pathway. | Not every HCC qualifies. |
| Insurance | Usually self-pay for international patients. | UAE resident insurance or government eligibility can change access. | Get written approval. |
| Stay length | Long monitoring near hospital is more affordable. | UAE stay is convenient for residents but costly for self-pay. | Weeks may be needed. |
| Follow-up | Needs home hepatologist handover. | UAE residents may continue drug levels locally. | Plan lifelong labs. |
Read the estimate
Donor tests, donor surgery, recipient surgery, ICU, medicines, and follow-up need separate lines.
Living donor, deceased donor, resident eligibility, and facility licensing must be verified.
Recipient ICU, donor monitoring, ventilation, dialysis, and infection support shape the estimate.
Immunosuppression, infection prophylaxis, and drug levels continue after discharge.
Bleeding, rejection, bile leak, vascular thrombosis, kidney failure, and infection can alter cost quickly.
Clinical scope
Requires medically suitable donor, free consent, relationship documentation, and donor safety review.
Governed by national allocation and cannot be treated as purchasable access.
MELD, ascites, encephalopathy, bleeding, kidney function, and infection shape risk.
Tumor size, number, AFP, imaging, and bridging therapy determine eligibility discussions.
Requires specialized ICU, anesthesia, donor, and emergency transfer planning.
When India may fit
India may fit when donor documents are strong and lower total pathway cost matters.
Lower nearby stay and lab cost can support several weeks of early follow-up.
Delhi NCR, Chennai, Hyderabad, Mumbai, Kochi, and Ahmedabad can be compared for transplant depth.
Families can request staged estimates for donor, recipient, ICU, medicines, and complications.
When UAE may fit
UAE may fit if the licensed facility accepts the case and coverage is documented.
UAE-based families may prefer local donor, caregiver, and home support.
Only licensed UAE transplant pathways should be considered.
UAE transplant care may require a larger reserve for ICU and medicines.
Cost comparison
| Hospital package | India local | India USD | AED | Comparator USD | Scope |
|---|---|---|---|---|---|
| Standard living donor pathway | INR 35,00,000-65,00,000 | USD 42,000-78,000 | AED 4,40,000-8,80,000 | USD 1,19,800-2,39,600 | Donor and recipient workup, surgery, ICU, medicines, and early follow-up. |
| Complex cirrhosis or HCC route | INR 55,00,000-95,00,000+ | USD 66,000-1,14,000+ | AED 6,60,000-13,00,000+ | USD 1,79,750-3,54,000+ | High MELD, HCC bridging, infection, kidney support, extra ICU, or blood products. |
| Pediatric or acute high-acuity route | INR 50,00,000-1,10,00,000+ | USD 60,000-1,32,000+ | AED 7,50,000-16,00,000+ | USD 2,04,200-4,35,600+ | Pediatric ICU, acute liver failure, metabolic disease, or reoperation risk. |
| Extended care | India local | India USD | AED | Comparator USD | Scope |
|---|---|---|---|---|---|
| Donor extended review | INR 2,00,000-6,00,000 | USD 2,400-7,200 | AED 25,000-90,000 | USD 6,805-24,510 | CT volumetry, donor specialist clearances, psychology, consent, and documents. |
| Extra ICU and ventilation | INR 1,00,000-3,50,000/day | USD 1,200-4,200/day | AED 12,000-40,000/day | USD 3,270-10,890/day | Ventilation, renal support, sepsis, bleeding, or graft dysfunction. |
| Post-discharge medicines and labs | INR 60,000-2,80,000/month | USD 720-3,360/month | AED 7,000-35,000/month | USD 1,905-9,530/month | Immunosuppression, drug levels, liver labs, kidney labs, and infection prophylaxis. |
| Intervention or reoperation reserve | INR 4,00,000-25,00,000+ | USD 4,800-30,000+ | AED 50,000-3,50,000+ | USD 13,615-95,300+ | Biliary intervention, vascular procedure, drain, bleeding control, or return to theater. |
| Complete trip budget | India local | India USD | AED | Comparator USD | Scope |
|---|---|---|---|---|---|
| Patient, donor, caregiver flights | Origin dependent | USD 800-4,500+ | Origin dependent | USD 150-2,500+ | Flexible tickets needed because authorization and ICU course can change timing. |
| Visa or medical entry | Nationality dependent | Varies | AED 200-900+ fees before deposits | USD 55-245+ | Patient, donor, and caregiver documents may need translation and extensions. |
| Long nearby stay | INR 3,000-14,000/night | USD 35-170/night | AED 300-1,200/night | USD 82-327/night | Several weeks near transplant hospital may be needed. |
| Caregiver daily cost | INR 2,000-9,000/day | USD 25-110/day | AED 250-900/day | USD 68-245/day | Caregiver manages medicines, food, warning signs, and appointments. |
| Local transport | INR 1,000-6,000/visit | USD 12-72/visit | AED 80-350/visit | USD 22-95/visit | Frequent labs and clinic visits after discharge. |
| Food and infection supplies | INR 1,20,000-4,00,000/month | USD 1,440-4,800/month | AED 5,000-18,000/month | USD 1,360-4,900/month | Safe food, masks, hygiene, wound items, and medicine storage. |
| Emergency reserve | INR 8,00,000-30,00,000+ | USD 9,600-36,000+ | AED 1,00,000-5,00,000+ | USD 27,225-1,36,125+ | ICU, reoperation, infection, rejection, kidney failure, or delayed return. |
| Home hepatology setup | INR 80,000-3,00,000 | USD 960-3,600 | AED 8,000-35,000 | USD 2,180-9,530 | Hepatologist, labs, drug levels, medicine supply, and tele-review. |
Usually included
MELD labs, imaging, infection, cardiac, kidney, anesthesia, nutrition, and hepatology review.
Repeat tests vary.
Blood group, CT volumetry, liver function, viral markers, psychology, and independent review.
Donor safety.
Document review and legal pathway support where permitted.
No guarantee.
Transplant surgery, anesthesia, operating room, graft implantation, and routine disposables.
Complexity varies.
Donor hepatectomy, anesthesia, ICU or ward, and donor recovery care.
Separate cost.
Specified included days for donor and recipient.
Extra days major.
Initial immunosuppression, prophylaxis, pain relief, and routine post-op drugs.
Brand matters.
Labs, wound checks, drug-level adjustment, and discharge summary.
Visit count.
Confirm separately
Buying organs, brokered donors, or false documents must be rejected.
Illegal.
Allocation cannot be bought or guaranteed for international patients.
Regulated.
Ventilation, dialysis, sepsis, bleeding, or graft dysfunction can exceed package limits.
Daily rates.
TACE, ablation, systemic treatment, or repeat imaging for HCC may be separate.
Stage dependent.
Reoperation, vascular thrombosis, bile leak, rejection, renal failure, or infection treatment.
Reserve.
Immunosuppression and labs continue for life.
Home budget.
UAE coverage may not approve every drug, admission, or transplant pathway.
Check approval.
Unexpected long stay may need visa extension, accommodation, and caregiver changes.
Plan early.
Cost drivers
MELD, kidney function, infection, malnutrition, encephalopathy, and ICU status shape risk.
Major driver.
Anatomy, liver volume, steatosis, relationship proof, and donor health change workup.
Safety first.
Vascular, biliary, and size concerns can increase time and resources.
Imaging.
HCC criteria, AFP, tumor number, and bridging treatment affect eligibility.
Tumor board.
Ventilation, bleeding, kidney support, infection, and graft function drive cost.
Reserve.
Cells, plasma, platelets, albumin, and coagulation products can be substantial.
Ask units.
UAE access and out-of-pocket cost can depend on facility acceptance and coverage.
Verify.
Immunosuppression, antivirals, antifungals, antibiotics, and drug-level tests continue.
Long term.
Hospital selection
Verify that the exact UAE or India hospital is permitted for transplant work.
Campus-specific.
Independent donor assessment, volumetry, consent, and counseling should be documented.
Protect donor.
Transplant hepatology, surgery, ICU, anesthesia, infection, radiology, and nephrology should coordinate.
Team care.
Confirm ventilator, dialysis, isolation, blood bank, and rapid intervention access.
Critical.
The hospital should explain donor documents, authorization, and resident or foreign patient limits.
Policy check.
UAE residents need written approval and scope of covered transplant services.
Coverage.
Medicine supply, lab schedule, emergency signs, and home hepatologist handover are required.
Continuity.
Treating team
Leads severity review, infection control, medicine plan, and long-term monitoring.
Explains recipient surgery, donor surgery, graft anatomy, and escalation plan.
Evaluates donor independently and protects donor health even when recipient need is urgent.
Important for high MELD, cardiac risk, kidney dysfunction, ventilation, and blood products.
Should continue labs, drug levels, infection watch, and urgent care after return.
Patient journey
Share diagnosis, labs, MELD inputs, imaging, endoscopy, medicines, infection results, and donor details.
Ask if transplant is appropriate now or if stabilization, cancer bridging, or infection treatment is needed first.
Review blood group, relationship proof, donor health, imaging needs, and consent requirements.
Check facility licensing, organ law, donor rules, and insurance before deposits.
Separate recipient, donor, ICU, medicines, complications, travel, and follow-up.
Travel only when patient and donor can safely move.
Before discharge, arrange labs, medicine access, warning signs, and home specialist handover.
Get hepatology travel clearance, infection status, bleeding risk, and donor document readiness.
Unsafe patients need local care.
Use flexible tickets for patient, donor, and caregiver.
Dates change.
A caregiver must stay through admission, discharge, medicine learning, and early follow-up.
Essential.
Choose accommodation near transplant hospital with safe food and emergency transport.
Weeks needed.
Donor travel should follow medical and legal review only.
No brokers.
Return after graft function, drug levels, wound status, infection control, and emergency plan are clear.
Written note.
Arrange LFT, tacrolimus level, CBC, kidney function, infection watch, and medicines.
Before departure.
Liver transplant in India requires organ-specific hospital authorization and living-donor legal review.
UAE rules regulate donation and transplantation, ban organ trafficking, and require licensed pathways.
Relationship proof, donor consent, identity documents, and medical suitability must be reviewed.
Reject any paid donor access, guaranteed graft, or shortcut paperwork.
Safety and risks
High-risk liver disease can deteriorate despite expert care.
No guarantee.
Living donors face surgical and long-term risks.
Independent review.
Major bleeding or vascular thrombosis may need urgent intervention.
Blood bank.
Cirrhosis, surgery, ICU, and immunosuppression increase infection risk.
Fever plan.
Biliary problems may need ERCP, drains, stents, or surgery.
Backup.
Dialysis support may be needed before or after transplant.
Nephrology.
False donor documents or commercial organ access can create criminal and medical harm.
Reject shortcuts.
Recovery and continuity
Frequent labs, wound checks, infection watch, and drug-level adjustment are expected.
Donor pain, wound, liver function, and activity restrictions need follow-up too.
Plan several weeks of medicines and confirm home availability.
Carry operative notes, graft details, drug list, lab schedule, and emergency signs.
Tele-review helps but cannot replace urgent local care for fever, jaundice, bleeding, confusion, or low urine.
Drug levels, liver function, kidney function, infection screening, and cancer surveillance continue.
Complications or slow recovery can delay return and increase stay cost.
Decision guide
India may fit when donor files are strong and lower long-stay cost matters.
UAE may fit if licensed facility acceptance and coverage are documented.
Neither destination should be chosen until local stabilization and transfer safety are clear.
| Factor | India may fit when | UAE may fit when | Verify before booking |
|---|---|---|---|
| Donor route | Family donor documents and legal review can be prepared. | UAE licensed pathway accepts donor route. | Donor documents. |
| Budget | Lower donor-recipient and long-stay budget is important. | Higher UAE private-care budget or coverage is available. | Staged estimate. |
| Authorization | NOTTO and hospital permission can be checked. | UAE law and facility license are documented. | Official source. |
| Acuity | Patient can travel and liver ICU is appropriate. | UAE center accepts severity and ICU needs. | Hepatology clearance. |
| Cancer | HCC criteria and bridging plan are documented. | UAE team confirms eligibility and allocation route. | Tumor board. |
| Follow-up | Home hepatologist can continue drug levels and labs. | UAE resident follow-up may be local. | Calendar. |
Reports and questions
Cause, complications, admissions, endoscopy, ascites, encephalopathy, and bleeding.
Bilirubin, INR, creatinine, sodium, albumin, CBC, and kidney status.
Triphasic CT or MRI, portal vein status, and liver cancer staging if applicable.
AFP, tumor size and number, biopsy if done, bridging treatment, and oncology notes.
Blood group, relationship, age, health history, prior tests, and willingness.
HBV, HCV, HIV, TB, cultures, recent fever, antibiotics, and vaccination record.
Diuretics, lactulose, rifaximin, anticoagulants, diabetes drugs, and allergies.
Origin, visa status, caregiver, budget, urgency, and home hepatologist access.
Ask tests, CT volumetry, psychology, anesthesia, and repeat tests.
Ask document support and committee costs without approval guarantee.
Separate donor and recipient ICU or ward assumptions.
Ask unit limits and pricing for extra products.
Clarify immunosuppression, antivirals, antifungals, antibiotics, albumin, and drug levels.
Ask reoperation, biliary intervention, vascular procedure, dialysis, and ventilation rates.
Ask discharge criteria, nearby stay duration, and return-flight clearance.
Ask lab calendar, emergency contact, home doctor handover, and medicine supply.
Ask if stabilization, nutrition, infection treatment, or cancer bridging should happen first.
Discuss blood group, liver volume, anatomy, medical risk, and consent.
Ask how MELD, kidney function, infection, age, nutrition, and ICU status affect risk.
Ask about authorization, donor findings, infection, cancer staging, and clearance.
Fever, jaundice, confusion, bleeding, abdominal pain, breathlessness, or low urine need urgent care.
Assign a named hepatologist or transplant physician before return.
Related guidance
Common questions
India is usually lower for the full donor-recipient pathway, ICU, medicines, nearby stay, and early monitoring.
Only a licensed UAE transplant facility can confirm eligibility, donor route, legal rules, insurance, and acceptance.
No. Commercial organ arrangements, brokered donors, and false documents are illegal and unsafe.
Recipient severity, donor workup, ICU days, blood products, infection, kidney support, bile leak, rejection, and medicines.
No. Deceased donor allocation is regulated and cannot be bought or guaranteed.
Many patients need several weeks near the transplant center for labs and drug-level adjustment.
Liver diagnosis, MELD labs, imaging, endoscopy, infection tests, donor blood group, relationship proof, and medicines.
Yes, but coverage must be written and facility-specific before the family relies on it.
Confusion, active bleeding, severe infection, kidney failure, breathlessness, shock, or worsening jaundice may require local care.
Virello can organize reports, prepare quote questions, and compare legal, medical, and travel assumptions.
Method and sources
This liver transplant comparison separates donor-recipient workup, legal route, licensed facility acceptance, ICU, blood products, medicines, insurance, allocation safeguards, medical visa rules, and currency references. It uses UAE medical visa, UAE organ law, India medical visa, NOTTO, WHO transplantation, CBUAE, and FBIL references. Contact support@virellohealth.com for report-led coordination.
Need a report-led comparison?
Virello Health can help organize the case summary, quote questions, hospital scope, and practical next steps. For written communication, use support@virellohealth.com.